News Releases

Synlogic to Present at the 2022 National PKU Alliance (NPKUA) Conference

Synlogic to Present at the 2022 HCU Network America, Organic Acidemia Association and Propionic Acidemia Foundation Conference

Synlogic Reminds Stockholders of 2022 Annual General Meeting Details

Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1618 for the Treatment of Phenylketonuria

Synlogic Reports First Quarter 2022 Financial Results and Provides Business Update

Synlogic Announces First Quarter 2022 Conference Call and Webcast

Synlogic Announces Data Presentations at the 2022 Genetic Metabolic Dieticians International (GMDI) Conference and Garrod Symposium

Synlogic Announces Data Presentations from Five Programs at the 2022 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference

Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for Inherited Metabolic Disorders 43rd Annual Meeting

Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Synlogic Announces Fourth Quarter and Full Year 2021 Conference Call and Webcast

Synlogic Announces Appointment of Michael Jensen as Chief Financial Officer

Synlogic Therapeutics